SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?


To: John McCarthy who wrote (404)5/11/1998 2:42:00 PM
From: MJ  Respond to of 1510
 
John

Question---is it possible that both are driving the stock?

Both are autoimmune diseases and symptoms are very close in the end stages with a break down of the immune system. Given this similarity is it possible that the treatments can be similar.

This comes from someone who has had several family members with RA who are now deceased. Having witnessed one of these go through the disease from start to finish and die, I now understand some of the similarities of RA with AIDS.

RA has its genetic propensity, hence I am investing with the hope of my money doing some good for all and for our family.

MJ



To: John McCarthy who wrote (404)5/11/1998 4:48:00 PM
From: Robert DeHaven  Read Replies (2) | Respond to of 1510
 
IMHO...John: Buying is driving this stock.

For what reason are people buying because 1) The rotation of investment has come to biotechs 2)This company is coming to the end of a long expensive road involving trials of Remune 3) The RA business is promising 4) They also have promising applications involving gene therapy....

Fast track approval of Remune has been speculated.
Corporate partnerships have been rumoured and hinted at by the company and PR.
Private Placement at above market prices
Institutional interest is now apparant.
Prudential started coverage with a buy last week...and is also making a market in the stock....

Very strong bullish driving forces...

good luck,

bob